Documentary brings to the screen the lasting impact and major importance of organ donation across the country.

The James Kreppner Award program supports legal research relevant to Canadian Blood Services. Research priorities for the James Kreppner Award include the legal and regulatory aspects of (a) donation, collection, storage, and use of blood, blood products, and hematopoietic stem cells; and (b) organ and tissue donation and transplantation. The 2016 James Kreppner Award will support one project with up to $50,000 for a period of one year. This year’s competition closes Nov. 30 2016.

Did you know that Canadian Blood Services directly funds innovative research?

When tragedy strikes, expert guidance helps doctors, patients and families take action

A new and improved site to learn, share and advance in the fields of transfusion and transplantation medicine After much hard work, collaboration and consultation, we're pleased to announce the launch of a new and improved online educational platform for health-care professionals. Canadian Blood Services has a mandate to strengthen and support professional development in the fields of transfusion and transplantation science and medicine to ultimately benefit patients while ensuring donor safety. We are also committed to promoting awareness and education about organ and tissue donation and

Two hundred and fifty donations facilitated through the Highly Sensitized Patient program We are pleased to share the news of an exciting milestone for the Highly Sensitized Patient program. As of Monday, Aug. 22, 2016, there have been 250 transplants since going live in October 2013! The Highly Sensitized Patient (HSP) program is a national organ sharing program operated by Canadian Blood Services in collaboration with all provincial donation and transplant programs The program gives provincial transplant programs access to a larger national pool of kidney donors for highly sensitized

Dr. Peter Nickerson awarded the AST Clinical Science Established Investigator Award.

On June 9, The Ottawa Hospital announced an exciting breakthrough treatment for some MS patients. The clinical trial , supported by our autologous stem cell program, was just published in The Lancet and has received world-wide media attention.

Congratulations to Mike Halpenny and team for their award-winning presentation at CBMTG 2016.

On that front, Canada is doing a very good job. Dr. David Allan, medical director for Canadian Blood Services’ Cord Blood Bank and OneMatch Stem Cell and Marrow Network, reports that more than 1,000 units of cord blood are now available in the public Cord Blood Bank.